Cancer Drugs Up to 93% Cheaper as NPPA Revises 543 MRPs
India’s drug price regulator has revised the maximum retail prices of 543 cancer drug brands and pack sizes, delivering reductions of more than 90 percent in several cases. The National Pharmaceutical Pricing Authority’s latest intervention targets non-scheduled anti-cancer medicines and is expected to bring meaningful relief for many patients, particularly those relying on generic and…